Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo (original) (raw)
References
Matrisian LM, 1992, The matrix-degrading metalloproteinases. Bioessays, 14, 455–63. Google Scholar
Woessner JF, 1991, Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J, 5, 2145–54. Google Scholar
Stetler-Stevenson WG, Krutzsch HC and Liotta LA, 1989, Tissue inhibitor of metalloproteinase (TIMP-2): A new member of the metalloproteinase inhibitor family. J Biol Chem, 264, 17374–8. Google Scholar
Goldberg GI, Marmer BL, Grant GA, et al. 1989, Human 72-kDa type IV collagenase forms a complex with tissue inhibitor of metalloproteinase designated TIMP-2. Proc Natl Acad Sci USA, 86, 8207–11. Google Scholar
Goldberg GI, Strongin A, Collier IE, Genrich LT and Marmer BL, 1992, Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinase prevents dimerization, complex formation with interstitial collagenase and activation of the proenzyme with stromelysin. J Biol Chem, 267, 4583–91. Google Scholar
Howard EW, Bullen EC and Banda MJ, 1991, Regulation of autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinase-2. J Biol Chem, 266, 13064–9. Google Scholar
Circola A, Welgus HG, Pierce GF, Kramer K and Strunk RC, 1991, Differential regulation of the expression of proteinase/antiproteinases in fibroblasts. J Biol Chem, 266, 12283–8. Google Scholar
Nomura S, Hogan BLM, Wills AJ, Heath JK and Edwards DR, 1989, Developmental expression of tissue inhibitor of metalloproteinase (TIMP) RNA. Development, 105, 575–83. Google Scholar
Sato H, Kida Y, Mai M et al, 1992, Expression of genes encoding type IV collagen degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene, 7, 77–83. Google Scholar
Rutka JT, Myatt CA, Giblin JR, Davis RL and Rosenblum ML, 1987, Distribution of extracellular matrix proteins in primary human brain tumors: an immunohistochemical analysis. Can J Neurol Sci, 14, 25–30. Google Scholar
Lund-Johansen M, Rucklidge GJ, Milne G and Bjerkvig RA, 1991, Metalloproteinase capable of destroying cultured brain tissue isolated from rat glioma cells. Anticancer Res, 11, 1000–6. Google Scholar
Nakano A, Tani E, Miyazaki K, Furuyama J and Matsummoto T, 1993, Expression of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun, 192, 999–1003. Google Scholar
Rao JS, Steck PA, Mohanam S, et al. 1993, Elevated levels of M, 92 000 type IV collagenase in human brain tumors. Cancer Res, 53, 2208–11. Google Scholar
Bradford MM, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem, 72, 248–254. Google Scholar
Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT and Liotta LA, 1990, Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem, 265, 13833–8. Google Scholar
Mohanam S, Sawaya R, McCutcheon I, et al. 1993, Modulation of in vitro invasion of human glioblastoma cells by urokinase type plasminogen activator receptor antibody. Cancer Res, 53, 4143–7. Google Scholar
Kubota S, Fridman R and Yamada Y, 1992, Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease. Biochem Biophys Res Commun, 176, 129–36. Google Scholar
Mackay AR, Ballin M, Pelina MD, et al. 1992, Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Inv Metastasis, 12, 168–84. Google Scholar
Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ and Edward DR, 1993, Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol Res, 5, 19–28. Google Scholar
Apodaca G, Rutka JT, Bouhana K, et al. 1990, Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res, 50, 2322–39. Google Scholar
Campo E, Merino MJ, Tavassoli FA, et al. 1992, Evaluation of basement membrane components and the 72-kDa type IV collagenase in serous tumors of the ovary. Am J Surg Pathol, 16, 500–7. Google Scholar
Monteagudo C, Merino MJ, San-Juan J, Liotta LA and Stetler-Stevenson WG, 1990, Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissues. Am J Pathol, 136, 585–92. Google Scholar
Stearns ME and Wanga M, 1993, Type IV collagenase (Mr 72000) expression in human prostate: benign and malignant tissue. Cancer Res, 5, 878–83. Google Scholar
Okada Y, Tsuchiya H, Shimizu H, et al. 1990, Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun, 171, 610–7. Google Scholar
Overall VM, Wrana JL and Sodek J, 1991, Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor β-1 in human fibroblasts. J Biol Chem, 266, 14064–71. Google Scholar
DeClerck YA, Yean TD, Ratzkin BJ, Lu HS and Langley KE, 1989, Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem, 264, 17445–53. Google Scholar
Kokha R and Ruther U, 1993, Transgenic mice with hepatic TIMP-1 alteration: a model to study the role of TIMP-1 in liver carcinogenesis. Proc AACR, 34, 121. Google Scholar
Fridman R, Bird RE, Hoyhtya M, et al. 1993, Expression of human recombinant 72-kDa gelatinase and tissue inhibitor of metalloproteinase-2 (TIMP-2): characterization of complex and free enzyme. Biochem J, 289, 411–6. Google Scholar
Strongin AY, Marmer BL, Grang GA and Goldberg GI, 1993, Plasma membrane dependent activation of the 72 kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem, 268, 14033–9. Google Scholar
Khokha R, Zimmer MJ, Graham CH, Lala PK and Waterhouse P, 1992, Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells. JNCI, 84, 1017–22. Google Scholar
Testa JE, 1992, Loss of the metastatic phenotype by a human epidermoid carcinoma cell line HEp-3 is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. Cancer Res, 53, 5597–603. Google Scholar
Alvarez OA, Carmichael DF and De Clerck YA, 1990, Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinase. JNCI, 82, 589–95. Google Scholar
Tsuchiya Y, Sato H, Endo Y, et al. 1993, Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line KKLS in the chick embryo. Cancer Res, 53, 1397–402. Google Scholar
De Clerck YA, Perez N, Shimada H, et al. 1992, Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res, 52, 701–8. Google Scholar